We use cookies on this site to provide you the best experience.

This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies, and how to delete or block the use of cookies, please read our Cookie Policy.

Can I take part?

Eligibility criteria

The cosMOG study is looking for about 100 people worldwide who:

  • Are between 18 and 89 years old
  • Have a confirmed diagnosis of MOG‑AD
  • Have relapsing MOG‑AD with at least one relapse in the last 12 months
  • Have a documented positive serum MOG antibody test using a cell-based assay within 6 months prior to randomization

There are additional eligibility criteria you need to meet to be able to participate in the study. The study team will discuss these with you.

Find your nearest study site

To find out if this study could be right for you, please contact the study site nearest you. If there are no locations near you, please check again later, as a site may become available in the future.

For help in participating in the study, you can get live support and, if eligible, get connected to a study site with the help of a Know Rare Patient Advocate. Click here.

If you have any further questions about how to participate in the cosMOG Study, you can contact UCBCares® at 844‑599‑CARE (2273) or ucbCARES@ucb.com.

Closest study sites

About the cosMOG study

The cosMOG study aims to understand how well-tolerated and effective an investigational drug called rozanolixizumab is in people with MOG‑AD. The investigational drug will be given weekly as an infusion under the skin.

With no approved treatment options for MOG‑AD, we understand that your treatment journey may not have been an easy one. Clinical research studies, also called clinical trials, are a necessary and vital step toward understanding rare diseases such as MOG‑AD and how to treat them.

With your help, the cosMOG study will evaluate if an investigational drug can prolong the time between relapses for people with this condition.

Learn more about this study

Are you eligible?

You may be eligible to take part in the cosMOG study if you (among other things):

  • Are between 18 and 89 years old
  • Have a confirmed diagnosis of MOG‑AD
  • Have relapsing MOG‑AD with at least one relapse in the last 12 months
  • Have a positive MOG antibody test within 6 months prior to first dosing
Find a study site near you
null

This page is for healthcare providers only.

Are you a healthcare provider?

Yes

You are about to leave cosmogstudy.com. You will be redirected to
outbound url.
Do you want to continue?

Yes

The content you are trying to access is no longer available.

Share

Copy page link

Send from your email account

Navigate to default email client